-
NUMBER OF INSIDER BUYING
(Last 12 Months)
0 -
NUMBER OF INSIDER SELLING
(Last 12 Months)
8 -
AMOUNT OF INSIDERS BUYING
(Last 12 Months)
$0 -
AMOUNT OF INSIDERS SELLING
(Last 12 Months)
$44.20 M
Intra-Cellular Therapies, Inc. Insider Transactions
Intra-Cellular Therapies, Inc. Insider Trades History
| Insider Name | Buy/Sell | Shares Bought/Sold @ Price |
Total Transaction | Shares Held After Transaction |
Transaction Date | Filing Date | Details |
|---|---|---|---|---|---|---|---|
|
Halstead Michael
President |
Sell | 13,371 @ $88.17 | $1.18 M | 5,343 | 11/13/2024 | 11/14/2024 | |
|
Halstead Michael
President |
Sell | 5,343 @ $88.92 | $475,100 | 0 | 11/13/2024 | 11/14/2024 | |
|
Halstead Michael
President |
Sell | 15,105 @ $88.72 | $1.34 M | 7,764 | 11/12/2024 | 11/14/2024 | |
|
Halstead Michael
President |
Sell | 6,116 @ $89.63 | $548,177 | 1,648 | 11/12/2024 | 11/14/2024 | |
|
Halstead Michael
President |
Sell | 1,648 @ $90.89 | $149,787 | 0 | 11/12/2024 | 11/14/2024 | |
|
Mates Sharon
CEO |
Sell | 28,203 @ $72.73 | $2.05 M | 1,076,522 | 08/30/2024 | 08/30/2024 | |
|
Mates Sharon
CEO |
Sell | 6,193 @ $73.32 | $454,091 | 1,070,329 | 08/30/2024 | 08/30/2024 | |
|
Mates Sharon
CEO |
Sell | 29,832 @ $72.44 | $2.16 M | 1,076,101 | 08/29/2024 | 08/30/2024 | |
|
Mates Sharon
CEO |
Sell | 5,772 @ $73.25 | $422,771 | 1,070,329 | 08/29/2024 | 08/30/2024 | |
|
Mates Sharon
CEO |
Sell | 32,459 @ $72.74 | $2.36 M | 1,070,569 | 08/28/2024 | 08/28/2024 | |
|
Mates Sharon
CEO |
Sell | 240 @ $73.70 | $17,688 | 1,070,329 | 08/28/2024 | 08/28/2024 | |
|
Mates Sharon
CEO |
Sell | 23,657 @ $73.33 | $1.73 M | 1,087,185 | 08/27/2024 | 08/28/2024 | |
|
Mates Sharon
CEO |
Sell | 16,856 @ $73.93 | $1.25 M | 1,070,329 | 08/27/2024 | 08/28/2024 | |
|
Mates Sharon
CEO |
Sell | 22,713 @ $74.59 | $1.69 M | 1,070,329 | 08/26/2024 | 08/28/2024 | |
|
Mates Sharon
CEO |
Sell | 28,680 @ $74.46 | $2.14 M | 1,070,329 | 08/23/2024 | 08/23/2024 | |
|
Mates Sharon
CEO |
Sell | 35,011 @ $74.58 | $2.61 M | 1,074,698 | 08/22/2024 | 08/23/2024 | |
|
Mates Sharon
CEO |
Sell | 4,369 @ $75.47 | $329,727 | 1,070,329 | 08/22/2024 | 08/23/2024 | |
|
Mates Sharon
CEO |
Sell | 44,134 @ $75.40 | $3.33 M | 1,079,208 | 08/21/2024 | 08/23/2024 | |
|
Mates Sharon
CEO |
Sell | 4,297 @ $76.20 | $327,432 | 1,074,911 | 08/21/2024 | 08/23/2024 | |
|
Mates Sharon
CEO |
Sell | 2,682 @ $77.21 | $207,088 | 1,072,229 | 08/21/2024 | 08/23/2024 |
Intra-Cellular Therapies, Inc. Congressional Trades History
| Member of congress | Current Price | Type | Trade Data | Date Filed | Date Traded |
|---|---|---|---|---|---|
| $82.47 | Sale | $1,001 - $15,000 | 07/09/2024 | 06/21/2024 |
Intra-Cellular Therapies, Inc. Frequently Asked Questions
-
Who is on Intra-Cellular Therapies, Inc.'s Insider Roster?
The list of insiders at Intra-Cellular Therapies, Inc. includes MARCUS JOEL S, Neumann Mark, Durgam Suresh K., Mates Sharon, Hineline Lawrence J., Halstead Michael, VAN NOSTRAND ROBERT L, RIGGS RORY B.
-
How much insider selling is happening at Intra-Cellular Therapies, Inc.?
Insiders have sold a total of 607,885 Intra-Cellular Therapies, Inc. shares in the last 12 months for a total of 44.20 M sold.
-
Which Intra-Cellular Therapies, Inc. insiders have been selling company stock?
The following insiders have sold Intra-Cellular Therapies, Inc. shares in the last 12 months: MARCUS JOEL S ($1.79 M), Neumann Mark ($3.32 M), Durgam Suresh K. ($864,193), Mates Sharon ($26.85 M), Hineline Lawrence J. ($2.47 M), Halstead Michael ($5.60 M), VAN NOSTRAND ROBERT L ($2.98 M), RIGGS RORY B ($337,193),